カテゴリー： Allied Market Research

特発性肺線維症の世界市場：薬品タイプ別（ピルフェニドン、ニンテダニブ）

Allied Market Researchが発行した調査報告書（AMR8040285）
◆英語タイトル：Idiopathic Pulmonary Fibrosis Market by Type of Drug (Pirfenidone, Nintedanib) and Region (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2017-2023
◆商品コード：AMR8040285
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2017年9月
◆ページ数：150
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：Medical Devices & Supplies
◆販売価格オプション（消費税別）
Single UserUSD5,370 ⇒換算￥558,480見積依頼/購入/質問フォーム
5 UserUSD5,910 ⇒換算￥614,640見積依頼/購入/質問フォーム
Enterprise UserUSD7,800 ⇒換算￥811,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
本資料は、特発性肺線維症の世界市場について調べ、特発性肺線維症の世界規模、市場シェア、市場動向、市場環境、薬品タイプ別（ピルフェニドン、ニンテダニブ）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・特発性肺線維症の世界市場概要
・特発性肺線維症の世界市場環境
・特発性肺線維症の世界市場動向
・特発性肺線維症の世界市場規模
・特発性肺線維症の世界市場：市場シェア
・特発性肺線維症の世界市場：薬品タイプ別（ピルフェニドン、ニンテダニブ）
・特発性肺線維症の世界市場：地域別市場規模・分析
・特発性肺線維症の北米市場規模・予測
・特発性肺線維症のアメリカ市場規模・予測
・特発性肺線維症のヨーロッパ市場規模・予測
・特発性肺線維症のアジア市場規模・予測
・特発性肺線維症の日本市場規模・予測
・特発性肺線維症の中国市場規模・予測
・関連企業情報
【レポートの概要】

Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.

The global idiopathic pulmonary fibrosis market generated $1,616 million in 2016, and is projected to reach $3,569 million by 2023, registering a CAGR of 11.9% during the study period. The major factors that drive the growth of the global idiopathic pulmonary fibrosis market include rise in prevalence of fibrotic disease and increase in geriatric population. In addition, surge in demand for cost-effective drugs and introduction of advanced treatment options propel the market growth. However, unavailability of the proper treatment options of the disease restricts the market growth.

The global idiopathic pulmonary fibrosis market is segmented on the basis of type of drug and region. According to type of drug, the market is divided into pirfenidone and nintedanib. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
This report provides an extensive analysis of the current and emerging market trends and dynamics in the market from 2016 to 2023 that helps identify the upcoming market opportunities.
Recent industry trends and developments and the future opportunities are also covered.
Extensive knowledge about the key market players and their strategies is provided.
Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

Key Market Segments

By Type of Drug

Pirfenidone
Nintedanib

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key market players

The key players operating in this market include
MediciNova, Inc.
Boehringer Ingelheim
F. Hoffmann-La Roche
FibroGen, Inc.
Promedior, Inc.
Merck & Co., Inc.
Galapagos NV
Biogen
Bristol-Myers Squibb Company
Prometic Life Sciences Inc.
Cipla Inc.

【レポートの目次】

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.4.4. Impact analysis

CHAPTER 4 GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET, BY DRUG TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PIRFENIDONE

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. NINTEDANIB

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 IDIOPATHIC PULMONARY FIBROSIS MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe

5.4. ASIA-PACFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. South Korea
5.4.8. Rest of Asia-Pacific

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

6.1. MEDICINOVA, INC.

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. BOEHRINGER INGELHEIM

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. F. HOFFMANN-LA ROCHE

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. FIBROGEN, INC.

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. PROMEDIOR, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MERCK & CO., INC.

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. GALAPAGOS NV

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. BIOGEN

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. BRISTOL-MYERS SQUIBB COMPANY

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. PROMETIC LIFE SCIENCES INC.

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

6.11. CIPLA INC.

6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves and developments

TABLE 1. GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 2. PIRFENIDONE MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 3. PIRFENIDONE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 4. NINTEDANIB MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 5. NINTEDANIB MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 6. IDIOPATHIC PULMONARY FIBROSIS MARKET, BY REGION, 2016-2023, ($MILLION)
TABLE 7. NORTH AMERICA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 8. NORTH AMERICA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 9. U.S. IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 10. CANADA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 11. MEXICO IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 12. EUROPE IDIOPATHIC PULMONARY FIBROSIS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 13. EUROPE IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 14. GERMANY IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 15. FRANCE IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 16. UK IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 17. ITALY IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 18. SPAIN IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 19. REST OF EUROPE IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 20. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 21. ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 22. JAPAN IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 23. CHINA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 24. INDIA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 25. SOUTH KOREA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 26. REST OF ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 27. LAMEA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 28. LAMEA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE, 2016-2023, ($MILLION)
TABLE 29. BRAZIL IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 30. SOUTH AFRICA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 31. SAUDI ARABIA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 32. REST OF LAMEA IDIOPATHIC PULMONARY FIBROSIS MARKET, BY TYPE OF DRUG, 2016-2023, ($MILLION)
TABLE 33. MEDICINOVA, INC.: COMPANY SNAPSHOT
TABLE 34. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 35. ROCHE: COMPANY SNAPSHOT
TABLE 36. FIBROGEN: COMPANY SNAPSHOT
TABLE 37. PROMEDIOR: COMPANY SNAPSHOT
TABLE 38. MERCK: COMPANY SNAPSHOT
TABLE 39. GALAPAGOS: COMPANY SNAPSHOT
TABLE 40. BIOGEN: COMPANY SNAPSHOT
TABLE 41. BRISTOL-MYERS SQUIBB COMPANY: COMPANY SNAPSHOT
TABLE 42. PROMETIC LIFE SCIENCES INC.: COMPANY SNAPSHOT
TABLE 43. CIPLA INC.: COMPANY SNAPSHOT

FIGURE 1. IDIOPATHIC PULMONARY FIBROSIS MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP INVESTMENT POCKETS
FIGURE 6. MARKET SHARE ANALYSIS, 2016
FIGURE 7. IMPACT ANALYSIS, 2016

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 特発性肺線維症の世界市場：薬品タイプ別（ピルフェニドン、ニンテダニブ）(Idiopathic Pulmonary Fibrosis Market by Type of Drug (Pirfenidone, Nintedanib) and Region (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2017-2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 構内用ケーブルの北米市場 North America Premise Cable Market is expected to reach $248 million in 2022 from $83,714 thousand in 2015, growing at a CAGR of 16.9% from 2016 to 2022. Premise cables refer to inter-building or intra-building networking cables, which are used for data transmission in telecommunication closets, server rooms, and entrance facilities. These cables are used for short-distance data transmission, that is, within the premises. However, these cables cover a distance of around hundred m when operated on their maximum data transfer rate. The growing demand for data on both fixed and mobile networks builds pressure on operators to invest in...
  • HIV薬の世界市場 Human Immunodeficiency Virus (Hiv) Attacks The Body’s Immune System, Making The Host System Susceptible To Infection, And Thus Leading To Complete Damage. The Virus Attacks The Cd4 Cells, Which Help The Immune System Defend Infections. The Major Route Of Transmission Of Hiv Infection Is Through Unprotected Sex, Use Of Contaminated Needle, Breast Milk Of The Hiv Infected Mother, And Infected Blood. The Global Hiv Drugs Market Was Valued At $20,448 Million In 2015, And Is Estimated To Reach $26,458 Million By 2022, Growing At A Cagr Of 3.7% During The Forecast Period From 2016 To 2022. The Major Factors That...
  • イーサネットケーブルの世界市場 Ethernet cable is one of the most prevalent types of network cable used in wired networks. It is used in local area networks (LANs) and metropolitan area networks (MANs). It connects and transmits broadband signals between a modem, router, computer, and other wired internet-enabled devices. This technology is used in more than 80% of LAN-connected PCs and workstations, as it is a reliable solution for providing real-time data and status updates to ensure constant information availability and instant data transfer. These cables are widely used across various industries for fast and secured data transfer. The world Ethernet cable market is...
  • ブロックチェーン分散型台帳の世界市場：タイプ別（民間、公的）、エンドユーザー別（政府機関、銀行・金融サービス・保険、自動車、小売業者・電子取引、メディア・エンターテイメント、その他） The global blockchain distributed ledger market accounted for $228 million in 2016, and is expected to reach $5,430 million by 2023, registering a CAGR of 57.6% from 2017 to 2023. Blockchain distributed ledger is a database, which serves as an online ledger keeping record of transactions that cannot be changed. In present connected and integrated world, economic activity occur in business networks that span national, geographical, and jurisdictional boundaries. Transactions involve various participants such as buyers, sellers, and intermediaries (such as banks, auditors, or solicitors) whose business agreements and contracts are recorded in ledgers. A blockchain is a tamper-proof, pooled...
  • グラファイトの世界市場：タイプ別（天然、人工）、用途別（潤滑剤、耐熱剤、鋳造、電池、その他） Global Graphite Market size was valued at $13,004 million in 2015, and is expected to reach $18,769 million by 2022, supported by a CAGR of 5.4% during the forecast period 2014 to 2022.Graphite is flexible in nature and has both metallic and non-metallic properties, which makes it appropriate for a diverse range of industrial applications. The non-metallic properties of graphite include high thermal resistance, chemical inertness, and lubricity, while the metallic properties include electrical and thermal conductivity. Graphite is manufactured synthetically using carbon containing raw materials such as tar pitch and petroleum coke. The demand for natural graphite is directly...
  • オフショア石油・ガス設備向け塗料およびコーティング剤の世界市場：樹脂タイプ別（エポキシ、ポリウレタン、アルキド、アクリル、無機亜鉛、その他）、設備別（ジャッキアップ型リグ、フローター型リグ、ドリルシップ型リグ、セミサブマーシブル型リグ、その他） The global offshore oil & gas paint and coatings market is expected to reach $620 million by 2023 from $378 million in 2016, and, registering a CAGR of 7.3% from 2017 to 2023. Offshore oil & gas exploration activities lead to formation of foul and corrosion layers on the vessel equipment, which are further coated system to provide protection. Moreover, continuous contact with rough seawater and prolonged exposure to penetrating UV rays adversely affect the life of coating systems. Therefore, in offshore environments, long resistant coatings are expected to provide a long service life. Moreover, these coatings require advanced personnel...
  • 海洋風力エネルギーの世界市場： The global offshore wind energy market was valued at $2,727 thousand in 2016, and is expected to reach $11,334 thousand by 2023, registering a CAGR of 19.4% from 2017 to 2023. Offshore wind energy is used by numerous countries globally to harness the energy of consistent and strong winds, which are specifically around the oceans. Offshore winds are more uniform and process higher speed than on land. The energy produced from wind is directly proportional to the cube of the wind speed. Thus, wind speeds of only a few miles per hour are able to generate a considerably larger amount...
  • マルチタッチスクリーンの世界市場：技術別（抵抗式、容量式、赤外線式、光学式、その他）、用途別（家電製品、小売、教育、その他） The global multi-touch screen market was valued at $6 billion in 2016, and is projected to reach $16 billion by 2023, growing at a CAGR of 15.9% from 2017 to 2023. Multi-touch screens are an update to the single touch screen technology. Unlike single touch technology in which operator can chose a single point, move, click, and slide with a single finger or one touch stylus, multi-touch technologies can distinguish between numerous touch inputs on a single screen and respond accordingly. Smartphones and tablets, multi-touch screens are used in tabletop PCs, such as Microsoft’s SurfaceTM. Moreover, they are used in...
  • 可食性パッケージングの世界市場：素材別（脂質、多糖類、タンパク質、界面活性剤、複合フィルム）、エンドユーザー別（食品・飲料、医薬品） Edible packaging refers to the environment-friendly technique for packaging of various food items. The packaging is made up of renewable resources and is completely non-toxic and biodegradable and considered safe for human consumption. Moreover, edible films and coatings allow the products to be fresh and help enhance the food quality, product shelf life, and food safety. The ingredients used in the packaging include antioxidants and antimicrobials, which conserve food quality by creating an enhanced oxygen barrier property. Edible films are made up of lipids, proteins, and polysaccharides, which is expected to be easily consumed with the food products and are...
  • 騒音レベル計の世界市場：タイプ別（通常型騒音レベル計、精密型騒音レベル計）、用途別（工場・企業、環境保護、交通機関、研究開発、その他） A sound level meter is a handheld instrument with a microphone used for acoustic measurements by determining sound pressure. The diaphragm of the microphone responds to changes in air pressure caused by sound waves. This movement of the diaphragm, which involves, the sound pressure deviation, is therefore converted into an electrical signal. The sound level meter needs to know the sensitivity of the particular microphone being used. Through this information, the instrument can accurately convert the electrical signal back to a sound pressure and display the resulting sound pressure level. The global sound level meters market is expected to reach...
  • サーバー用マイクロプロセッサの世界市場：設計別（ARM、x86）、エンドユーザー別（大規模企業、中規模企業、小規模企業） The global server microprocessor market was valued at $14 billion in 2016, and is projected to reach at $16 billion by 2023, growing at a CAGR of 2.1% from 2017 to 2023. Server microprocessor is a semiconductor device, which executes various computational tasks on the server in a single integrated circuit. A microprocessor is a multipurpose, clock-driven, register-based component, which accept binary digits (0 and 1) and process according to the instructions stored in the memory giving output into various forms such as displayed on the monitor, hard copy, and others. The global server microprocessor market is driven by factors...
  • 爆発物探知機の世界市場：技術別（爆薬の痕跡のためのスクリーニング装置、バルクの爆発物探知機）、製品タイプ別（車載、ハンドヘルド、ロボット、その他）、エンドユーザー別（軍事・防衛、貨物輸送、航空、公共の場所、その他） global explosive detector market accounted for $4,531 million in 2016, and is expected to reach $8,208 million by 2023, registering a CAGR of 8.7% from 2017 to 2023. Explosive detectors are non-destructive inspection devices that help its users in detecting explosives and other flammable materials. It is commonly used at airports, seaports, borders of countries, and in important structures such as the government buildings. The detection of explosives at airports, land borders, and seaports is an essential task for preventing terrorism and organized crime. Owing to terrorist use of explosive devices, strong interest has been focused towards the development of...
  • 抗体薬物複合体の世界市場：薬剤別（アドセトリス、カドサイラ）、作用機序別（CD30抗体、HER2抗体）、用途別（乳がん、リンパ腫） The antibody drug conjugates market was valued at $1,387 million in 2016, and is estimated to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023. Antibody drug conjugates (ADC’s) are promising and effective anticancer medications employed for efficient treatment of cancer patients. ADC’s are biopharmaceutical drugs prepared by integrating two clinical approaches viz cell killing HPAPI (powerful pharmaceutical ingredient) and monoclonal antibody specificity. This combination approach enables elimination of cancer infected cells without harming healthy cells in patient’s body. Increase in global prevalence of cancer and demand for quality & cost-effective cancer medications drives the...
  • 垂直農法の世界市場：コンポーネント別（灌漑栽培用コンポーネント、照明器具、センサー、環境制御、建材、その他）、栽培方法別（水耕栽培、エアロポニックス、アクアポニックス） The global vertical farming market was valued at $1.5 billion in 2016, and is projected to reach $6.4billion by 2023, growing at a CAGR of 23.6% from 2017 to 2023. Vertical farming is a nontraditional method to grow crops, which enables ease of harvesting, no effect of climate, high yield, minimal usage of pesticides, less area requirement, and less water consumption. For instance, one hectare of vertical farming is equivalent to nine hectares of traditional outdoor farming, and saves nearly 200 tons of water on a daily basis. Aeroponics, a growth mechanism of vertical farming uses mist, mixed with vital...
  • 整備済みDNAシーケンシングプラットフォームの世界市場 The global refurbished DNA sequencing platforms market was valued at $41 million in 2016 and is expected to reach $112 million in 2023, registering a CAGR of 15.0% from 2017 to 2023. DNA sequencing is a technology in which several DNA strands could be sequenced through massive parallelization. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages DNA sequencing offers over microarray and other genomic analysis methods. Refurbished and used DNA sequencing platforms are relatively inexpensive instruments used for DNA sequencing, when compared with new DNA sequencing platforms. In addition, the...